Jaguar Health extends maturity of $6.22M secured note to Jan 20, 2026

Jaguar Health, Inc.

Note originally issued Jan 19, 2021; maturity extended from undated to Jan 20, 2026.
Principal amount remains $6,220,812.50; no other terms changed publicly.
Amendment dated Feb 13, 2025 between Jaguar Health, Napo Pharma, and Streeterville Capital.
Extension provides additional time to repay; no default or acceleration mentioned.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.